Finance
Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with…
SILVER ONE PROVIDES UPDATE ON METALLURGICAL TEST RESULTS USING INNOVATIVE…
Leafbuyer Technologies, Inc. Announces Record Results: 20% Increase in Quarterly…
ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important…
EYLEA HD ® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular…
New to The Street Premieres Back-to-Back Episodes on Bloomberg: Episode 624 Aired Last Night, Episode…
Three-Year Results for EYLEA HD ® (aflibercept) Injection 8 mg in Patients with Wet Age-related…
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and…
SAVA IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with…
Advertisement
